Showing results (51-60 of 304) with videos related to
Sort By:
Pageof 31
Expert Opinion on Investigational Drugs|July 2, 2005
Olanzapine (Zyprexa):characteristics of a new antipsychoticC A Tamminga, J M KanePsychopharmacology|January 1, 1979
Treatment of Schizophrenia with ergot derivativesC A Tamminga, M H SchafferNeuroscience|July 28, 2015
Schizophrenia: Evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiologyC A Tamminga, R S ZukinCurrent Pharmaceutical Biotechnology|January 31, 2012
Treating impaired cognition in schizophreniaH M Ibrahim, C A TammingaDialogues in Clinical Neuroscience|October 29, 2011
Treatments for chronic psychosisC A Tamminga, A C LahtiExpert Opinion on Investigational Drugs|July 2, 2005
Sertindole (Serdolect): preclinical and clinical findings of a new atypical antipsychoticJ M Kane, C A TammingaSynapse (New York, N.Y.)|August 1, 1996
Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48-hour time courseX M Gao, C A TammingaPeptides|May 1, 1982
Brain endopeptidase generates enkephalin from striatal precursorsM Knight, C Plotkin, C A TammingaThe Journal of Biological Chemistry|August 25, 1978
In vivo distribution of phosphothioredoxin and thioredoxin in Escherichia coliR R Conley, V PigietJournal of Computer Assisted Tomography|September 1, 1993
PET-FDG test-retest reliability during a visual discrimination task in schizophreniaH H Holcomb, N G Cascella, D R Medoff, et al.Pageof 31